Findings

What do systematic reviews say?

3,241 questions · 3,336 findings · 1,340 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1,581 · 47.4%GRADE not reported 352 · 10.6%Very low 512 · 15.3%Low 509 · 15.3%Moderate 316 · 9.5%High 66 · 2%

14 days on/off antibiotic regimen vs 28 days on/off antibiotic regimen

Health‐related quality of life · people with bronchiectasis

2 findings from 1 review

Intermittent prophylactic antibiotics for bronchiectasis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
High
Intermittent prophylactic antibiotics for bronchiectasis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
High

14 days on/off antibiotic regimen vs 14 days on/off placebo regimen

Health‐related quality of life · people with bronchiectasis

2 findings from 1 review

Intermittent prophylactic antibiotics for bronchiectasis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
High
Intermittent prophylactic antibiotics for bronchiectasis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Moderate

Ginkgo biloba vs placebo

Health‐related quality of life · adults with tinnitus

1 finding from 1 review

Ginkgo biloba for tinnitus 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Low

Gingko biloba with concurrent intervention vs concurrent intervention only

Health‐related quality of life · adults with tinnitus

The review found no eligible studies for this question.

1 finding from 1 review

Ginkgo biloba for tinnitus 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Passive information provision vs control

Quality of life ‐ not measured · stroke carers

The review found no eligible studies for this question.

1 finding from 1 review

Information provision for stroke survivors and their carers 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Antibiotics vs placebo or no intervention

Quality of life at 24±6 months · patients with coronary heart disease

The review found no eligible studies for this question.

1 finding from 1 review

Antibiotics for secondary prevention of coronary heart disease 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Botulinum toxin type A vs anticholinergics

Health‐related quality of life · cervical dystonia

1 finding from 1 review

Botulinum toxin type A versus anticholinergics for cervical dystonia 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Postoperative use of LNG‐IUD vs postoperative GnRH‐a

Quality of life at 12 months Â

The review found no eligible studies for this question.

1 finding from 1 review

Levonorgestrel‐releasing intrauterine device (LNG‐IUD) for symptomatic endometriosis following surgery 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Postoperative use of LNG‐IUD vs expectant management

Quality of life at 12 months Â · Patients with symptomatic endometriosis following surgery

1 finding from 1 review

Levonorgestrel‐releasing intrauterine device (LNG‐IUD) for symptomatic endometriosis following surgery 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 55 participants
Very low

Vitamin K antagonist (VKA) prophylaxis vs no prophylaxis

Quality of life ‐ not reported · ambulatory people with cancer without venous thromboembolism receiving systemic therapy

The review found no eligible studies for this question.

1 finding from 1 review

Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Fondaparinux vs heparin

Quality of life ‐ not reported · patients with cancer with venous thromboembolism

The review found no eligible studies for this question.

1 finding from 1 review

Anticoagulation for the initial treatment of venous thromboembolism in people with cancer 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Dalteparin vs tinzaparin

Quality of life ‐ not reported · patients with the initial treatment of venous thromboembolism in patients with cancer

The review found no eligible studies for this question.

1 finding from 1 review

Anticoagulation for the initial treatment of venous thromboembolism in people with cancer 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Low molecular weight heparin vs unfractionated heparin

Quality of life ‐ not reported · patients with cancer with venous thromboembolism

The review found no eligible studies for this question.

1 finding from 1 review

Anticoagulation for the initial treatment of venous thromboembolism in people with cancer 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ LUNA (laparoscopic uterosacral ligament nerve ablation) vs diagnostic laparoscopy/other treatments

Quality of life ‐ not reported · health problem or population

The review found no eligible studies for this question.

1 finding from 1 review

Surgical interventions for the management of chronic pelvic pain in women 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Arginine butyrate plus standard care alone vs usual care

Quality of life ‐ not reported · individuals with sickle cell disease and a leg ulcer

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for treating leg ulcers in people with sickle cell disease 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Propionyl‐L‐carnitine vs placebo

Quality of life ‐ not reported · individuals with sickle cell disease and a leg ulcer

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for treating leg ulcers in people with sickle cell disease 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

RGD peptide matrix vs placebo

Quality of life ‐ not reported · individuals with sickle cell disease and a leg ulcer

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for treating leg ulcers in people with sickle cell disease 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Solcoseryl vs antiseptic agent

Quality of life ‐ not reported · individuals with sickle cell disease and a leg ulcer

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for treating leg ulcers in people with sickle cell disease 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Duoderm® (hydroactive dressing) vs antiseptic agent

Quality of life ‐ not reported · individuals with sickle cell disease and a leg ulcer

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for treating leg ulcers in people with sickle cell disease 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Isoxsuprine vs placebo

Quality of life ‐ not reported · individuals with sickle cell disease and a leg ulcer

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for treating leg ulcers in people with sickle cell disease 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found